Back to GetFilings.com



Table of Contents

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549

FORM 10-Q

(Mark One)
         
[X]
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
FOR THE QUARTERLY PERIOD
ENDED JUNE 30, 2002
 
   
 
 
 
OR
 
 
[_]
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
FOR THE TRANSITION PERIOD
FROM                           TO                          
 
   

COMMISSION FILE NUMBER 000-26124

IXYS CORPORATION
(Exact name of registrant as specified in its charter)

   
DELAWARE
(State or other jurisdiction
of incorporation or organization)
77-0140882
(IRS Employer Identification No.)

3540 BASSETT STREET
SANTA CLARA, CALIFORNIA 95054-2704

(Address of principal executive offices and Zip Code)

(408) 982-0700
(Registrant’s telephone number, including area code)

     Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

Yes [X]      No [_]

THE NUMBER OF SHARES OF THE REGISTRANT’S COMMON STOCK, $0.01 PAR VALUE, OUTSTANDING AS OF AUGUST 12, 2002, WAS 31,826,692.

 


TABLE OF CONTENTS

PART I — FINANCIAL INFORMATION
ITEM 1. FINANCIAL STATEMENTS
CONDENSED CONSOLIDATED BALANCE SHEETS
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
CONDENSED CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES OF MARKET RISK
PART II — OTHER INFORMATION
ITEM 1. LEGAL PROCEEDINGS
ITEM 2. CHANGES IN SECURITIES AND USE OF PROCEEDS
ITEM 3. DEFAULTS UPON SENIOR SECURITIES
ITEM 4. SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS
ITEM 5. OTHER INFORMATION
ITEM 6. EXHIBITS AND REPORTS ON FORM 8-K
SIGNATURES
EXHIBIT INDEX
EXHIBIT 10.29
EXHIBIT 10.30
EXHIBIT 10.31
EXHIBIT 99.1


Table of Contents

IXYS CORPORATION

INDEX
                 
PART I - FINANCIAL INFORMATION 1  
 
ITEM 1. FINANCIAL STATEMENTS 1  
 
        CONDENSED CONSOLIDATED BALANCE SHEETS     1  
 
        CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS     2  
 
        CONDENSED CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME     3  
 
        CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS     4  
 
        NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS     5  
 
ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATION 12  
 
ITEM 3.   QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK     24  
 
PART II - OTHER INFORMATION 25  
 
ITEM 1.   LEGAL PROCEEDINGS     25  
 
ITEM 2.   CHANGES IN SECURITIES AND USE OF PROCEEDS     26  
 
ITEM 3.   DEFAULTS UPON SENIOR SECURITIES     26  
 
ITEM 4.   SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS     26  
 
ITEM 5.   OTHER INFORMATION     26  
 
ITEM 6.   EXHIBITS AND REPORTS ON FORM 8-K     26  
 
SIGNATURES 27  

 


Table of Contents

PART I — FINANCIAL INFORMATION

ITEM 1. FINANCIAL STATEMENTS

IXYS CORPORATION
CONDENSED CONSOLIDATED BALANCE SHEETS

(in thousands, except share data)

                       
          June 30,   March 31,
          2002   2002
         
 
          (unaudited)
ASSETS
Current assets:
               
Cash and cash equivalents
  $ 42,851     $ 32,111  
Restricted cash
    2,651       205  
Accounts receivable, net of allowance for doubtful accounts of $1,875 at June 30, 2002 and $1,045 at March 31, 2002
    23,086       16,697  
Inventories
    55,395       46,317  
Prepaid expenses and other current assets
    2,453       596  
Deferred income taxes
    2,810       2,553  
 
   
     
 
 
Total current assets
    129,246       98,479  
Plant and equipment, net
    34,267       19,238  
Other assets
    24,067       4,828  
Deferred income taxes
    2,463       2,015  
 
   
     
 
 
Total assets
  $ 190,043     $ 124,560  
 
   
     
 
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
               
Current portion of capitalized lease obligations
  $ 2,795     $ 2,391  
Current portion of notes payable to bank
    769       700  
Accounts payable
    10,940       5,606  
Accrued expenses and other liabilities
    12,231       8,383  
 
   
     
 
 
Total current liabilities
    26,735       17,080  
Capitalized lease obligations, net of current portion
    5,687       4,770  
Loan payable
    136       118  
Pension liabilities
    8,422       7,373  
 
   
     
 
 
Total liabilities
    40,980       29,341  
 
   
     
 
Commitments and contingencies (Note 8)
               
Stockholders’ Equity
               
 
Preferred stock, $0.01 par value:
Authorized: 5,000,000 shares; none issued and outstanding
               
 
Common stock, $0.01 par value:
Authorized: 80,000,000 shares Issued and outstanding: 31,838,315 shares at June 30, 2002 and 26,827,192 shares at March 31, 2002
    318       268  
Additional paid-in capital
    144,319       92,785  
Notes receivable from stockholders
    (853 )     (853 )
Retained earnings
    5,113       5,827  
Less cost of treasury stock: 75,000 shares at June 30, 2002 and at March 31, 2002
    (445 )     (445 )
Accumulated other comprehensive income (loss)
    611       (2,363 )
 
   
     
 
Total stockholders’ equity
    149,063       95,219  
 
   
     
 
Total liabilities and stockholders’ equity
  $ 190,043     $ 124,560  
 
   
     
 

The accompanying notes are an integral part of these condensed consolidated financial statements.

1


Table of Contents

IXYS CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(in thousands, except per share data)

                       
          Three Months Ended
          June 30,
         
          2002   2001
         
 
          (unaudited)
Net revenues
  $ 27,437     $ 25,605  
Cost of goods sold
    19,978       17,299  
 
   
     
 
     
Gross profit
    7,459       8,306  
 
   
     
 
Operating expenses:
               
   
Research, development and engineering
    2,186       1,181  
   
Selling, general and administrative
    5,115       3,419  
   
Amortization of acquired intangible assets and goodwill
    90       58  
 
   
     
 
     
Total operating expenses
    7,391       4,658  
 
   
     
 
   
Operating income
    68       3,648  
Interest income
    203       341  
Interest expense
    (39 )     (195 )
Other (expense) income, net
    (1,352 )     (1,238 )
 
   
     
 
 
Income (loss) before income tax provision (benefit)
    (1,120 )     2,556  
 
Benefit from (provision for) income tax
    406       (970 )
 
   
     
 
Net income (loss)
  $ (714 )   $ 1,586  
 
   
     
 
Net income (loss) per share — basic
  $ (0.03 )   $ 0.06  
 
   
     
 
Weighted average shares used in per share calculation — basic
    27,999       26,690  
 
   
     
 
Net income (loss) per share — diluted
  $ (0.03 )   $ 0.05  
 
   
     
 
Weighted average shares used in per share calculation — diluted
    27,999       29,180  
 
   
     
 

The accompanying notes are an integral part of these condensed consolidated financial statements.

2


Table of Contents

IXYS CORPORATION
CONDENSED CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME

(in thousands)

                   
      Three Months Ended
      June 30,
     
      2002   2001
     
 
      (unaudited)
Net income (loss)
  $ (714 )   $ 1,586  
Other comprehensive income:
               
 
Foreign currency translation adjustments
    2,974       75  
 
   
     
 
 
Comprehensive income
  $ 2,260     $ 1,661  
 
   
     
 

The accompanying notes are an integral part of these condensed consolidated financial statements.

3


Table of Contents

IXYS CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(in thousands)

                   
      Three Months Ended
      June 30,
     
      2002   2001
     
 
      (unaudited)
Cash flows from operating activities:
               
Net income (loss)
  $ (714 )   $ 1,586  
Adjustments to reconcile net income to net cash provided by (used in) operating activities:
               
Depreciation
    1,409       816  
Amortization of intangible assets and goodwill
    90       58  
Provision for doubtful accounts
    291       (151 )
Provision for excess and obsolete inventory
          786  
Gain on disposal of assets
          (5 )
Deferred income taxes
    (660 )      
Loss on foreign currency transactions
    38       (159 )
Changes in operating assets and liabilities :
               
Accounts receivable
    (1,307 )     2,299  
Inventories
    2,185       (4,282 )
Prepaid expenses and other current assets
    (986 )     (16 )
Other assets
    (889 )     (373 )
Accounts payable
    1,246       (3,580 )
Accrued expenses and other liabilities
    (759 )     (419 )
Pension liabilities
    123       54  
 
   
     
 
 
Net cash provided by (used in) operating activities
    67       (3,386 )
 
   
     
 
Cash flows from investing activities:
               
Restricted cash
    (114 )     (17 )
Net cash acquired in acquisition of Clare, Inc.
    7,906        
Cash received for tax refund claims acquired from Clare
    2,500        
Proceeds from disposal of assets
          5  
Purchase of plant and equipment
    (63 )     (638 )
 
   
     
 
 
Net cash provided by (used in) investing activities
    10,229       (650 )
 
   
     
 
Cash flows from financing activities:
               
Proceeds from capital lease obligations
          75  
Principal payments on capital lease obligations
    (722 )     (672 )
Repayment of notes payable to bank
          (48 )
Proceeds from exercise of options
    68       169  
Proceeds from issuance of shares under ESPP
    112       194  
 
   
     
 
Net cash used in financing activities
    (542 )     (282 )
 
   
     
 
Effect of foreign exchange rate fluctuations on cash and cash equivalents
    986       (351 )
 
   
     
 
Net increase (decrease) in cash and cash equivalents
    10,740       (4,669 )
Cash and cash equivalents at beginning of period
    32,111       44,795  
 
   
     
 
Cash and cash equivalents at end of period
  $ 42,851     $ 40,126  
 
   
     
 

The accompanying notes are an integral part of these condensed consolidated financial statements.

4


Table of Contents

IXYS CORPORATION

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

1. Condensed Consolidated Financial Statements

The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with the instructions to Form 10-Q and do not include all of the information and footnotes required by accounting principles generally accepted in the United States of America for complete financial statements. The condensed consolidated financial statements include the accounts of IXYS Corporation (“IXYS” or the “Company”) and its wholly-owned subsidiaries. All significant intercompany transactions have been eliminated in consolidation. All adjustments of a normal recurring nature that, in the opinion of management, are necessary for a fair statement of the results for the interim periods have been made. It is recommended that the interim financial statements be read in conjunction with the Company’s audited consolidated financial statements and notes thereto for the fiscal year ended March 31, 2002 contained in the Company’s Annual Report on Form 10-K. Interim results are not necessarily indicative of the operating results expected for later quarters or the full fiscal year. Certain reclassifications have been made to the prior period’s condensed consolidated financial statements to conform to the current period’s presentation. Such reclassifications had no effect on previously reported results of operations or retained earnings.

Effective as of the beginning of the first quarter of fiscal year 2003, the Company completed the adoption of Statement of Financial Accounting Standards (SFAS) No. 141 (SFAS 141), “Business Combinations,” and SFAS No. 142 (SFAS 142), “Goodwill and Other Intangible Assets.” SFAS 141 requires all business combinations initiated after June 30, 2001 to be accounted for using the purchase method of accounting. As required by SFAS 142, the Company discontinued amortizing the remaining balance of goodwill as of the beginning of fiscal year 2003. All remaining and future acquired goodwill will be subject to impairment tests, annually or earlier if indicators of potential impairment exist, using a fair-value-based-approach. All other intangible assets will continue to be amortized over their estimated useful lives and assessed for impairment under SFAS No. 144, “Accounting for the impairment of Disposal of Long-lived Assets.” In conjunction with the implementation of SFAS 142, the Company has completed a goodwill impairment review as of the beginning of fiscal year 2003 and found no impairment. Had SFAS 142 been implemented at the beginning of the first quarter of fiscal year 2002, the pro forma effect of excluding goodwill amortization expense would have been as follows:

         
      3 Months Ended    
      June 30, 2001    
     
 
Reported net income     $ 1,586  
Add back: Goodwill amortization     58  
     
 
Pro forma net income     $ 1,644  
     
 
Reported net income per share        
     Basic income per common share     $ 0.06  
     Diluted income per common share     $ 0.05  
Add back: Goodwill amortization per share                
     Basic income per common share     $ 0.00  
     Diluted income per common share     $ 0.01  
Pro forma net income per share        
     Basic income per common share     $ 0.06  
     Diluted income per common share     $ 0.06  

2. Foreign Currency Translation

The local currency is considered to be the functional currency of IXYS’ wholly owned foreign subsidiaries. Accordingly, assets and liabilities are translated at the exchange rate in effect at period-end and revenues and expenses are translated at average rates during the period. Adjustments resulting from the translation of the accounts of IXYS’ foreign subsidiaries into U.S. dollars are included in cumulative translation adjustment, a separate component of stockholders’ equity. Foreign currency transaction gains and losses are included as a component of non-operating income and expense.

5


Table of Contents

3. Acquisition of Clare, Inc.

On June 10, 2002, IXYS completed its acquisition of Clare, Inc. (“Clare”). The acquisition of Clare was intended to allow the combined organization to be more competitive and to achieve greater financial strength, operational efficiencies, access to capital and growth potential than either company could separately achieve. In connection with the acquisition, (a) each outstanding share of Clare common stock was converted into the right to receive 0.49147 of a share of IXYS common stock, which will result in the issuance of approximately 4.9 million shares of IXYS common stock, and (b) each option to purchase Clare common stock outstanding immediately prior to the consummation of the acquisition was converted into an option to purchase 0.49147 of a share of IXYS common stock, resulting in the assumption of options exercisable for approximately 1.0 million shares of IXYS Common Stock.

The estimated total purchase price is as follows (in thousands):

         
Value of IXYS common stock issued     $47,658  
Value of IXYS options issued     3,676  
Estimated direct merger costs     1,722  
     
 
Total purchase price     $53,056  
     
 

IXYS is in the process of determining the fair values of identifiable intangible assets acquired and plant and equipment. IXYS is in the process of determining reasonable replacement costs to determine the fair value of plant and equipment acquired. IXYS is further determining the benefits achievable from contractual agreements to determine their fair value at the acquisition date. Based on preliminary estimates and draft valuations, IXYS preliminarily allocated the purchase price to identifiable intangible assets, tangible assets, liabilities assumed and goodwill as follows (in thousands):

                   
Fair value of tangible assets acquired:
             
 
Current assets
  $ 24,861        
 
Deferred tax assets, short term
    2,742        
 
Plant and equipment
    13,613        
 
Other assets
    111        
 
   
       
 
  $ 41,327        
Amortizable intangible assets:
            Estimated useful lives
 
           
 
Contractual agreement
    3,100       3 years
 
Core technology
    2,700       5 to 6 years
 
Tradename / Trademarks
    900       3 years
 
Other
    440       3 months to 6 years
 
   
       
 
    7,140        
 
   
       
 
Total assets acquired
    48,467        
Fair value of liabilities assumed
    (7,941 )      
 
   
       
 
Net assets acquired
    40,526        
 
Goodwill
    12,530        
 
   
       
 
Total purchase price
  $ 53,056        
 
   
       

6


Table of Contents

Pro Forma Disclosure (in thousands, except per share data):

The following unaudited pro forma combined amounts give effect to the acquisition of Clare as if the acquisitions had occurred on April 1, 2002 and 2001. On a pro forma basis, the results of operations of Clare for the three-month periods ended June 30, 2002 and 2001 are consolidated with IXYS results for the three-month periods ended June 30, 2002 and 2001. The pro forma amounts do not purport to be indicative of what would have occurred had the acquisition been made as of the beginning of each period or of results which may occur in the future.

                 
    Three Months Ended
    June 30,
   <